Skip to main content
Medical Affairs
Our Company
Who We Are
Leadership
Focus Areas
Overview
Oncology
Immunology & Inflammation
Neurology
Pipeline
Ongoing Clinical Trials
Presentations & Publications
Patients & Care Partners
Expanded Access
Healthcare Professionals (Coming soon!)
Our Medicines
Join Us
Our Culture
Open Positions
News
Ono Pharma
ONO-2808
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy (NCT05923866)
Neurology
Disease/Condition: Multiple system atrophy (MSA)
Back to top
